Cargando…

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

The promise of drug repurposing is that existing drugs may be used for new disease indications in order to curb the high costs and time for approval. The goal of computational methods for drug repurposing is to enable solutions for safer, cheaper and faster drug discovery. Towards this end, we devel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Regan, Kelly, Moosavinasab, Soheil, Payne, Philip, Lin, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MyJove Corporation 2016
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226396/ https://www.ncbi.nlm.nih.gov/pubmed/28060329 http://dx.doi.org/10.3791/54948

Ejemplares similares

‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities
por: Moosavinasab, Soheil, et al.
Publicado: (2016)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Drug Repurposing for the Treatment of Acute Myeloid Leukemia
por: Andresen, Vibeke, et al.
Publicado: (2017)

The Repurposing Drugs in Oncology (ReDO) Project
por: Pantziarka, Pan, et al.
Publicado: (2014)

Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma
por: Regan-Fendt, Kelly, et al.
Publicado: (2020)

ReDO_DB: the repurposing drugs in oncology database
por: Pantziarka, Pan, et al.
Publicado: (2018)

Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements
por: Frega, Giorgio, et al.
Publicado: (2020)

Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?
por: Devaux, Christian A., et al.
Publicado: (2021)

Identification of Trypanosoma cruzi Polyamine Transport Inhibitors by Computational Drug Repurposing
por: Reigada, Chantal, et al.
Publicado: (2019)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Repurposing drugs in oncology (ReDO)—cimetidine as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent
por: Van Nuffel, An MT, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent
por: Sukhatme, Vidula, et al.
Publicado: (2015)

Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

The failure of drug repurposing for COVID-19 as an effect of excessive hypothesis testing and weak mechanistic evidence
por: Maziarz, Mariusz, et al.
Publicado: (2022)

Text Mining and Data Modeling of Karyotypes to aid in Drug Repurposing Efforts
por: Abrams, Zachary B., et al.
Publicado: (2015)

Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review
por: Siddiqui, Shafina, et al.
Publicado: (2022)

Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
por: Verbaanderd, Ciska, et al.
Publicado: (2017)

Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugs
por: Oyarce, Cesar, et al.
Publicado: (2021)

Computational Screening Strategy for Drug Repurposing Identified Niclosamide as Inhibitor of Vascular Calcification
por: Tanaka, Takeshi, et al.
Publicado: (2022)

Repurposing Drugs in Small Animal Oncology
por: Giuliano, Antonio, et al.
Publicado: (2022)

Phenotypic screening of the ReFRAME drug repurposing library to discover new drugs for treating sickle cell disease
por: Metaferia, Belhu, et al.
Publicado: (2022)

Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020)

Drug repurposing in cardiology
por: van Driel, B. O., et al.
Publicado: (2020)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
por: Gouveia, Maria João, et al.
Publicado: (2018)

Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as anti-cancer agents
por: Pantziarka, Pan, et al.
Publicado: (2018)

The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis
por: Janes, Jeff, et al.
Publicado: (2018)

Repurposing of approved cardiovascular drugs
por: Ishida, Junichi, et al.
Publicado: (2016)

Drug repurposing with network reinforcement
por: Nam, Yonghyun, et al.
Publicado: (2019)

Repurposed Drugs in Gastric Cancer
por: Araújo, Diana, et al.
Publicado: (2022)

Computational Drug Repurposing Based on a Recommendation System and Drug–Drug Functional Pathway Similarity
por: Shao, Mengting, et al.
Publicado: (2022)

Drug repurposing—a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA)
por: McChord, Johanna, et al.
Publicado: (2023)

A Critical Review of the Bacterial Baptism Hypothesis and the Impact of Cesarean Delivery on the Infant Microbiome
por: Stinson, Lisa F., et al.
Publicado: (2018)

Conceptual Knowledge Discovery in Databases for Drug Combinations Predictions in Malignant Melanoma
por: Regan, Kelly, et al.
Publicado: (2015)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
por: March-Vila, Eric, et al.
Publicado: (2017)

Drug Repurposing: An Effective Tool in Modern Drug Discovery
por: Kulkarni, V. S., et al.
Publicado: (2023)

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
por: Sakai, Norihiro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g7kebi2c3ptbtmoef0k0kdeovv